Federal AI policy is pulling healthcare organizations in two directions: the FDA is reducing regulatory barriers for diagnostic

OpenAI's simultaneous launch of ChatGPT Health for consumers and enterprise solutions for hospitals marks an aggressive expansion into

Healthcare AI deployment has outpaced governance framework development, creating regulatory uncertainty and hidden risks. Recent FDA guidance easing

Utah has launched a groundbreaking program allowing AI to autonomously process prescription renewals without direct physician oversight. As

Artificial intelligence is rapidly moving from experimental technology to mainstream clinical tool. Recent developments show AI conducting patient

OpenAI's launch of ChatGPT Health for consumers and enterprise AI tools for healthcare organizations marks a significant expansion

Healthcare's approach to AI is maturing rapidly. In 2026, the focus has shifted from chasing innovation to prioritizing

Utah has become the first U.S. state to allow AI to autonomously approve prescription refills through a pilot

OpenAI's ChatGPT Health enables users to connect medical records and health app data for personalized AI insights, with

Utah has authorized AI to renew prescriptions while 40 million Americans turn to ChatGPT daily for health advice.